Register entry

Annora Pharma Private Limited

Data as of · How to read this entry

Registered sites
1
Active NDC listings
3
Live patents
0
Countries
1
Base
India
Authorisation

Registered operations

Analytical testing1Finished drug manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Annora Pharma Private LimitedSy. No.261, Plot No. 5,7,8,9,13 and 14, Annaram village, Gummadidal Mandal,, Sangareddy, Telangana 502313, India (IND)Analytical testing, Finished drug manufacture3013944676650980746
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: ANDA 3.

Dosage formNDCs
capsule, extended release3
RouteNDCs
oral3
Labeller name on the listingNDCs
annora pharma private limited3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDEcapsule, extended release, oral71785-1006ANDA
VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDEcapsule, extended release, oral71785-1007ANDA
VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDEcapsule, extended release, oral71785-1008ANDA
Neighbours

Registered in the same town

12
Compare

Comparable companies in India

Enquiry

Common questions

Is Annora Pharma Private Limited FDA approved?
Annora Pharma Private Limited holds 1 FDA-registered establishment in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Annora Pharma Private Limited's drugs manufactured?
The FDA register lists Sangareddy. Registered operations: analytical testing, finished drug manufacture.
What drugs does Annora Pharma Private Limited make?
3 products are listed under Annora Pharma Private Limited in the openFDA NDC Directory, most often as capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.